Navigation Links
Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results
Date:2/23/2010

evelopment pipeline of anticancer compounds at various stages of clinical testing, including carfilzomib, a next-generation proteasome inhibitor, that is currently being evaluated in multiple clinical trials for the treatment of patients with relapsed or relapsed/refractory multiple myeloma and solid tumors, and ONX 0801, a targeted alpha-folate inhibitor, currently in Phase 1 testing.  For more information about Onyx, visit http://www.onyx-pharm.com.

Nexavar® (sorafenib) tablets is a registered trademark of Bayer HealthCare Pharmaceuticals.

This news release contains "forward-looking statements" of Onyx within the meaning of the federal securities laws.  These forward-looking statements include, without limitation, statements regarding sales trends and commercial activities, the timing, progress and results of clinical development, regulatory filings and actions, the creation of opportunities for value creation and the integration of the operations and assets of Proteolix.  These statements are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated, including, but not limited to, risks and uncertainties related to:  Nexavar being our only approved product; competition; failures or delays in our clinical trials; dependence on our co
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Poniard Pharmaceuticals Secures $20 Million Committed Equity Financing Facility
2. Jazz Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Financial Results on March 3, 2010
3. Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010
4. Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Its Second Quarter of Fiscal Year 2010
5. Adamas Pharmaceuticals Announces In Vitro Data Demonstrating TCAD Therapy is More Potent Than Double Combinations or Monotherapy Against Drug-Resistant Flu Strains
6. Ritter Pharmaceuticals Joins NIH Conference Discussions on Lactose Intolerance and Associated Health Risks
7. Endo Pharmaceuticals Reports Strong Fourth Quarter and Full-Year 2009 Financial Results: Provides 2010 Financial Guidance
8. Alexza Pharmaceuticals Promotes Mark K. Oki to Vice President, Finance and Controller
9. Jazz Pharmaceuticals Announces FDA Acceptance of its New Drug Application for JZP-6 (sodium oxybate) for the Treatment of Fibromyalgia
10. Transdel Pharmaceuticals Announces Management Reorganization
11. Merz Pharmaceuticals Introduces New Mederma(R) Stretch Marks Therapy Now Available in Drugstores Nationwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... THOUSAND OAKS, Calif. , May 23, 2013 ... Deutsche Bank 38 th Annual  Healthcare Conference on Thursday, ... Boston , beginning at 9:20 a.m. Eastern Daylight ... Investor Relations at Amgen, will present at the conference. Live ... Calendar on Amgen,s website, www.amgen.com , under Investors. A ...
(Date:5/23/2013)... Minn. , May 23, 2013  MGC Diagnostics ... a global medical technology company, today scheduled a conference ... quarter of fiscal year 2013, ended April 30, 2013. ... Thursday, May 30, 2013. The Company will report financial ... after the markets close on Thursday, May 30, 2013. ...
(Date:5/23/2013)... May 23, 2013 More than half of ... benefit from chemotherapy and still have excellent outcomes. To ... one of the largest sources of online consumer information ... interactive Facebook page provide recently diagnosed women with information ... avoid chemotherapy. "We anticipate these innovative social ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3
... MIAMI, FL -- (MARKET WIRE) ... DOR BioPharma,Inc. (OTCBB: <a target="_blank" ... announced today that the European ... EP 1024827 B1, with claims ...
... -- Results from,the primary analysis of a ... 77 percent of treatment-experienced HIV-1,infected adults taking ... ritonavir (PREZISTA/r) twice daily, plus an optimized,background ... a,plasma viral load of <400 copies/mL at ...
Cached Medicine Technology:DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 2DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 3DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 4DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 5DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 6New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 3New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 4New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 5New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 6New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 7New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 8
(Date:5/23/2013)... United States Vice President Dick Cheney served as the ... , In front of 1,500 guests yesterday at ... "I am delighted to be here to have the ... Year Award. I think it's a tremendous recognition; I ... company like this because there are obviously a great ...
(Date:5/23/2013)... Spring and summer have always been motivation for people to ... city between Memphis and Nashville? In the last year alone, ... transformed the growing area into one of the most health-conscious ... vibrant, young professionals you are going to see demand for ... of The Fight Shop, one of the city’s hottest new ...
(Date:5/23/2013)... On April 29th, 2013, UV Technologies ... numbers of H7N9 cases and deaths. The headline read, " ... Will Subside in Northern Hemisphere as Available Daylight Increases .” ... been reported. , Quoting Kevin McGuire, president of UV ... flowers budding in the spring and leaves changing in the ...
(Date:5/23/2013)... York (PRWEB) May 23, 2013 Parker ... the rights of victims injured by defective medical devices ... Counsel Matthew J. McCauley has been appointed Co-Lead Counsel ... Mirena IUD Products Liability Litigation (Case 7:13-md-02434-CS). The Order, ... and Liaison Counsel are to submit their proposal for ...
(Date:5/23/2013)... EnvirOasis, the leader in energy efficient lighting ... pleased to announce its new line of Energy Star ... EnvirOasis has been a market leader in Fluorescent and ... has recently brought to market a full line of ... energy efficient lighting technology which produces a very high ...
Breaking Medicine News(10 mins):Health News:Acadian Ambulance Honors Paramedic of the Year at Annual Luncheon 2Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 2Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 3Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 4Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 2Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 3Health News:U.S. District Court Appoints Parker Waichman LLP’s Matthew J. McCauley to Leadership Role in Mirena IUD Litigation 2Health News:EnvirOasis Lighting Announces Energy Star and Design Lights Consortium LED Products 2
... of Advanced Nursing reports that many socially disadvantaged UK residents ... . ,A research across London by TB specialists ... trying to halt the spread of the disease. ... last 10 years and London is no exception" says lead ...
... seem to be becoming ever more hectic. With the result ... Australian children in the 10-15 year age group tend ... when compared with just one generation ago. ,Increased ... are to blame, with adolescents no longer adhering to 'lights ...
... State University held a prayer and yoga session during the ... friendship and a lot of learning together," said Kanchan Banerjee, ... after the event Saturday. ,It has been 17 ... ,More than 30 students sat barefoot and cross-legged and chanted ...
... researchers have concluded that almost 60 percent of Nebraska ... water bodies were declared impaired by federal and state ... method of testing was more conclusive in pinpointing the ... Effective pollution-control strategies can be developed only if researchers ...
... President Bush might make a show of laying wreaths on ... in the war on terror. ,But post traumatic stress disorder ... Families of veterans have begun to speak out, complaining that ... ,In the three months after Marine Maj. John Ruocco returned ...
... mini-couch potatoes, for a new study has found that kids ... chronic health problems in later life. ,As a ... examined activity levels of more than 3,500 students from five ... half of the kids hardly got any exercise, for they ...
Cached Medicine News:Health News:TB Patients in Marginalised Groups Need Social Support for Effective Medical Treatment 2Health News:Australian Children Sleep Less, Perhaps Not Well Monitored 2Health News:Fecal Bacteria, a Source of Contamination 2Health News:Suicide Among Returning US Soldiers on the Rise 2Health News:Suicide Among Returning US Soldiers on the Rise 3Health News:Suicide Among Returning US Soldiers on the Rise 4
... Hand-Held Pulse Oximeter provides SpO 2 and ... adult. The device is battery or AC ... visible and audible alarm signals, and an infrared ... rubber boot is also available for added protection. ...
... The FingerPrint Pulse Oximeter is a ... an integral printer. A light-weight, ... and pulse rate measurements, it ... 4 AA alkaline batteries, and has ...
... monitoring system compatible with personal computers ... rugged and cost-effective.The BCI 3301 HAND-HELD ... pulse oximetry wherever spot-checking is needed... ... and hospitals. In fact, its ergonomic ...
... Program is a Windows based, easy-to-use software ... Pulse Oximeter. Using the Smiths Medical ... rapidly downloads information collected during sleep screening, ... assists in the Clinician's interpretation by analyzing ...
Medicine Products: